Remember Me
Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:

OpenAIRE is about to release its new face with lots of new content and services.
During September, you may notice downtime in services, while some functionalities (e.g. user registration, login, validation, claiming) will be temporarily disabled.
We apologize for the inconvenience, please stay tuned!
For further information please contact helpdesk[at]openaire.eu

fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Barc, M.-C.; Depitre, C.; Corthier, G.; Karjalainen, T.; Bourlioux, P. (2011)
Publisher: Microbial Ecology in Health and Disease
Journal: Microbial Ecology in Health and Disease
Languages: English
Types: Article

Classified by OpenAIRE into

mesheuropmc: digestive, oral, and skin physiology
Germ-free mice associated with human faecal microorganisms were used as a model of the microbial barrier against C. difficile. In this model, the production of toxins A and B by C. difficile was studied after oral treatment with phenothiazines (chlorpromazine and cyamemazine), methotrexate and an antibiotic (clindamycin). After 4 wks oral administration of chlorpromazine (10 mg/kg/day) and cyamemazine (35 mg/kg/day), neither the number of C. difficile nor the levels of toxin A and B in faecal pellets differed from those of untreated mice. C. difficile failed to establish in the intestine of mice colonised with human faecal microorganisms; neither toxin A nor B were detected in the faecal pellets of these animals. After treatment with clindamycin (10 d; 75 mg/kg/day) and methotrexate (4 wks; 250 mg/kg/day), the concentration of C. difficile in the faecal pellets was stable, and toxin B, but not toxin A, was detected. These results show that both clindamycin and methotrexate are able to disturb the intestinal barrier effect, whereas phenothiazines had little such effect.Keywords - Clostridium difficile, Barrier microbiota, Colonisation resistance.

Share - Bookmark

Cite this article

Collected from

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok